If you have taken Reglan® or a generic equivilent and suffer from tardive dyskinesia, you may be entitled to compensation.
In February 2009, the Food and Drug Administration notified healthcare professionals that the manufacturers of metoclopramide drugs, including Reglan®, must add a boxed warning to their drug labels about the risk of its long-term or high-dose [...]

Explaining the Cases
Zicam is a popular non-prescription zinc nasal spray. Its manufacturer markets it as a medication to shorten the duration of the common cold. Zicam has been associated with the onset of a condition known as anosmia, which leaves the user with a [...]

Federal health regulators have issued a notice cautioning doctors about potential psychiatric side effects of the asthma drug Singulair and similar medicines. According to the Food and Drug Administration, drugs including Singulair, AstraZeneca Plc’s Accolate and Cornerstone Therapeutics Inc’s Zyflo and Zyflo CR may cause agitation, aggression, suicidal thinking, suicide, depression, insomnia and irritability. The [...]

Medicines used to treat attention-deficit hyperactivity disorder in children may increase the risk of sudden unexplained death, a new study has concluded. According to the study, funded by the Food and Drug Administration and the National Institute of Mental Health, children taking stimulant ADHD drugs such as Ritalin were several times more likely to die [...]

Eli Lilly marketed the antipsychotic drug Zyprexa for off-label use despite knowledge that was not effective, Bloomberg News reports. According to unsealed company documents, the drugmaker was aware that Zyprexa did not work on elderly patients with dementia but urged doctors to prescribe the drug anyway. The documents also showed that Lilly compiled an extensive [...]